Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Lien Vandenberk"'
Autor:
Lien Vandenberk, Paula Rodríguez-Otero, Maria-Victoria Mateos, Ajai Chari, Bhagirathbhai Dholaria, Deeksha Vishwamitra, Sheri Skerget, M Damiette Smit, Kalpana Bakshi, Sangmin Lee, Nizar Bahlis, Niels WCJ van de Donk, Raluca Verona
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/dbff19d26aaa4728b508224666963930
Autor:
Nizar J Bahlis, Katja Weisel, Maria-Victoria Mateos, Hartmut Goldschmidt, Tom Martin, Daniel Morillo, Donna Reece, Paula Rodríguez-Otero, Manisha Bhutani, Anita D’souza, Albert Oriol, Laura Rosiñol Dachs, Bhagirathbhai Dholaria, Kalpana Bakshi, Lijuan Kang, Lien Vandenberk, Damiette Smit, Ralph Wäsch, Niels W.C.J. van de Donk, Ajai Chari
Publikováno v:
HemaSphere, Vol 7, p e90062ca (2023)
Externí odkaz:
https://doaj.org/article/2bcd2dcc8c5c44adb5296cd4eb1544f2
Autor:
Abhishek D. Garg, Lien Vandenberk, Matthias Van Woensel, Jochen Belmans, Marco Schaaf, Louis Boon, Steven De Vleeschouwer, Patrizia Agostinis
Publikováno v:
OncoImmunology, Vol 6, Iss 4 (2017)
Glioblastoma (GBM) is resistant to most multimodal therapies. Clinical success of immune-checkpoint inhibitors (ICIs) has spurred interest in applying ICIs targeting CTLA4, PD1 or IDO1 against GBM. This amplifies the need to ascertain GBM's intrinsic
Externí odkaz:
https://doaj.org/article/3a0cee7e7812429bb36bd26111abdbdf
Autor:
Paula Rodríguez-Otero, Anita D'Souza, Donna Ellen Reece, Niels W.C.J. van de Donk, Ajai Chari, Amrita Y. Krishnan, Thomas G. Martin, Maria-Victoria Mateos, Daniel Morillo, David Duane Hurd, Laura Rosiñol, Anna Sureda Balari, Ralph Wäsch, Deeksha Vishwamitra, Shun Xin Wang Lin, Thomas Prior, Lien Vandenberk, Marie-Anne Damiette Smit, Albert Oriol Rocafiguera, Bhagirathbhai R. Dholaria
Publikováno v:
Journal of Clinical Oncology. 40:8032-8032
8032 Background: Teclistamab (tec; JNJ-64007957) is a BCMA × CD3 T-cell redirecting bispecific antibody under investigation in patients (pts) with RRMM. Daratumumab (dara) is a CD38 mAb with direct on-tumor and immunomodulatory actions. Initial clin
Autor:
Sofie Van Eygen, Matthias Van Woensel, Norbert Graf, Stefaan Van Gool, Tekele Fasche, Abhishek D. Garg, Carolien Koks, Jan Willem Maes, Peter de Witte, Patrizia Agostinis, Petri Salven, Shentong Fang, Niels Vanthillo, Lien Vandenberk
Publikováno v:
Cell Death & Differentiation. 24:832-843
Innate immune sensing of dying cells is modulated by several signals. Inflammatory chemokines-guided early recruitment, and pathogen-associated molecular patterns-triggered activation, of major anti-pathogenic innate immune cells like neutrophils dis
Autor:
Abhishek D. Garg, Lien Vandenberk, P. De Witte, Shentong Fang, Petri Salven, Patrizia Agostinis
Publikováno v:
Radiotherapy and Oncology. 133:S60
Autor:
Patrizia Agostinis, Stefaan Van Gool, Louis Boon, Abhishek D. Garg, Lien Vandenberk, Tina Verschuere, Carolien Koks
Publikováno v:
Science Translational Medicine. 8
The promise of dendritic cell (DC)-based immunotherapy has been established by two decades of translational research. Of the four malignancies most targeted with clinical DC immunotherapy, high-grade glioma (HGG) has shown the highest susceptibility.
Autor:
Stefaan Van Gool, Lien Vandenberk
Publikováno v:
Immunotherapy. 4:675-678
Evaluation of: Crane CA, Ahn BJ, Han SJ, Parsa AT. Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival and expansion of regulatory T cells: implications for immunotherapy. Neuro Oncol. 14(5), 584–595 (2012). Tregs p
Autor:
Steven De Vleeschouwer, Louis Boon, Abhishek D. Garg, Norbert Graf, Michael Ehrhardt, Carolien Koks, Patrizia Agostinis, Stefaan W. Van Gool, Matteo Riva, Lien Vandenberk
Publikováno v:
International Journal of Cancer. 136
The oncolytic features of several naturally oncolytic viruses have been shown on Glioblastoma Multiforme cell lines and in xenotransplant models. However, orthotopic glioma studies in immunocompetent animals are lacking. Here we investigated Newcastl
Publikováno v:
Klinische Pädiatrie. 225